Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H1/H2 Antagonists for Functional Dyspepsia
NCT07857941Phase 2Recruiting
- Sponsor
- Buddhist Tzu Chi General Hospital
- Start
- Jan 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 2 trial of famotidine, levocetirizine in functional dyspepsia (FD), sponsored by Buddhist Tzu Chi General Hospital. Started Jan 2025; status: recruiting.
02
Drugs
famotidinelevocetirizine
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT07857941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07857941.